You'll have to see if your doctor is following any protocols in preventing a stroke after your heart attack. I see nothing here that follows my ideas on stroke risk reduction;
My 11 Stroke risk reduction ideas.
Don't follow them, they are not medically proven
http://www.ncbi.nlm.nih.gov/pubmed/25236874
Abstract
BACKGROUND AND PURPOSE:
Ischemic
stroke after acute myocardial infarction is an important complication.
It is unknown whether the risk has changed because the treatment of
acute myocardial infarction has improved during the past decade. There
is also conflicting data about predictors of stroke risk.
METHODS:
To
obtain the 1-year incidence of stroke after acute myocardial
infarction, the Register of Information and Knowledge about Swedish
Heart Intensive Care Admissions database for the years 1998 to 2008 was
merged with the Swedish National Patient Register (NPR). The time trend
was studied by dividing the entire time period into 5 separate periods.
Independent predictors were identified using a multivariable Cox
proportional hazards regression model.
RESULTS:
Between
1998 and 2008, 7185 of 173 233 patients with acute myocardial
infarction had an ischemic stroke within 1 year (4.1%). There was a 20%
relative risk reduction during the study period (1998-2000 versus
2007-2008) relative risk 0.80 (95% confidence interval, 0.75-0.86;
P<0.001. Independent predictors of stroke were age, female sex,
ST-segment-elevation myocardial infarction, previous stroke, previous
diabetes mellitus, heart failure at admission, angiotensin-converting
enzyme inhibitor treatment and atrial fibrillation. Reperfusion
treatment with fibrinolysis and percutaneous coronary intervention and
treatment with aspirin, P2Y12-inhibitors, and statins predicted a
reduced risk of stroke.
CONCLUSIONS:
The
risk of ischemic stroke within a year after myocardial infarction is
substantial but has clearly been reduced during the studied time period.
The major predictive factors found to correlate well with previous
investigations. Reperfusion treatment, thrombocyte aggregation
inhibition, and lipid lowering are the main contributors to the observed
risk reduction.
No comments:
Post a Comment